Mardi Dier, EVP & CFO at Portola Pharma, holds 9.26K shares in Madrigal Pharmaceuticals (Ticker: MDGL), holds 6.43K shares in ACELYRIN, INC. (Ticker: SLRN), holds 66.69K shares in Ultragenyx Pharmaceutical (Ticker: RARE). Most recently, Mardi Dier Sold ― shares of Madrigal Pharmaceuticals on Mar 02, 2026 for an estimated value of $505.39K.
Mardi Dier latest transaction was an Informative Sell of $505.39K.
What was Mardi Dier's most profitable transaction?
Mardi Dier’s most profitable transaction was an Informative Sell of RARE stock on October 14, 2021. The return on the trade was 54.20%.
What is Mardi Dier's role in Portola Pharma?
Mardi Dier's role in Portola Pharma is EVP & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.